These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


97 related items for PubMed ID: 1786990

  • 21. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
    Finch AM, Vogen SM, Sherman SA, Kirnarsky L, Taylor SM, Sanderson SD.
    J Med Chem; 1997 Mar 14; 40(6):877-84. PubMed ID: 9083476
    [Abstract] [Full Text] [Related]

  • 22. Cellular receptors to the anaphylatoxins C3a and C5a.
    Huey R, Fukuoka Y, Hoeprich PD, Hugli TE.
    Biochem Soc Symp; 1986 Mar 14; 51():69-81. PubMed ID: 3545212
    [Abstract] [Full Text] [Related]

  • 23. Cigarette smoke extract increases C5a receptor expression in human bronchial epithelial cells.
    Allen-Gipson DS, Floreani AA, Heires AJ, Sanderson SD, MacDonald RG, Wyatt TA.
    J Pharmacol Exp Ther; 2005 Jul 14; 314(1):476-82. PubMed ID: 15843499
    [Abstract] [Full Text] [Related]

  • 24. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK, Finch AM, Pierens GK, Craik DJ, Taylor SM, Fairlie DP.
    J Med Chem; 1998 Aug 27; 41(18):3417-25. PubMed ID: 9719594
    [Abstract] [Full Text] [Related]

  • 25. Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding.
    Zhang X, Boyar W, Galakatos N, Gonnella NC.
    Protein Sci; 1997 Jan 27; 6(1):65-72. PubMed ID: 9007977
    [Abstract] [Full Text] [Related]

  • 26. C5a receptor and thymocyte apoptosis in sepsis.
    Riedemann NC, Guo RF, Laudes IJ, Keller K, Sarma VJ, Padgaonkar V, Zetoune FS, Ward PA.
    FASEB J; 2002 Jun 27; 16(8):887-8. PubMed ID: 12039868
    [Abstract] [Full Text] [Related]

  • 27. Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes.
    Woodruff TM, Strachan AJ, Sanderson SD, Monk PN, Wong AK, Fairlie DP, Taylor SM.
    Inflammation; 2001 Jun 27; 25(3):171-7. PubMed ID: 11403208
    [Abstract] [Full Text] [Related]

  • 28. Identification of the polymorphonuclear leukocyte C5a receptor.
    Rollins TE, Springer MS.
    J Biol Chem; 1985 Jun 25; 260(12):7157-60. PubMed ID: 3997862
    [Abstract] [Full Text] [Related]

  • 29. Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release.
    Schlaf G, Schieferdecker HL, Rothermel E, Jungermann K, Götze O.
    Lab Invest; 1999 Oct 25; 79(10):1287-97. PubMed ID: 10532591
    [Abstract] [Full Text] [Related]

  • 30. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP, Hugli TE, Bloor CM.
    Am J Pathol; 1980 Aug 25; 100(2):327-48. PubMed ID: 6967702
    [Abstract] [Full Text] [Related]

  • 31. Characterization of the binding of Bolton-Hunter labeled [125I]C5a to human neutrophil, monocyte and U-937 cell membranes.
    Braunwalder AF, Musmanno D, Galakatos N, Garlick RH, Haston WO, Rediske JJ, Wennogle L, Seligmann B, Sills MA.
    Mol Immunol; 1992 Nov 25; 29(11):1319-24. PubMed ID: 1406720
    [Abstract] [Full Text] [Related]

  • 32. Characterization of a receptor for C5a anaphylatoxin on human eosinophils.
    Gerard NP, Hodges MK, Drazen JM, Weller PF, Gerard C.
    J Biol Chem; 1989 Jan 25; 264(3):1760-6. PubMed ID: 2912983
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the C-terminal C5a effector site with short synthetic C5a analog peptides.
    Köhl J, Lübbers B, Klos A, Bautsch W, Casaretto M.
    Eur J Immunol; 1993 Mar 25; 23(3):646-52. PubMed ID: 8383599
    [Abstract] [Full Text] [Related]

  • 34. Identification of a receptor-binding region in the core segment of the human anaphylatoxin C5a.
    Vlattas I, Sytwu II, Dellureficio J, Stanton J, Braunwalder AF, Galakatos N, Kramer R, Seligmann B, Sills MA, Wasvary J.
    J Med Chem; 1994 Aug 19; 37(17):2783-90. PubMed ID: 8064805
    [Abstract] [Full Text] [Related]

  • 35. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.
    Finch AM, Wong AK, Paczkowski NJ, Wadi SK, Craik DJ, Fairlie DP, Taylor SM.
    J Med Chem; 1999 Jun 03; 42(11):1965-74. PubMed ID: 10354404
    [Abstract] [Full Text] [Related]

  • 36. A selection system to study C5a-C5a-receptor interactions: phage display of a novel C5a anaphylatoxin, Fos-C5aAla27.
    Hennecke M, Kola A, Baensch M, Wrede A, Klos A, Bautsch W, Köhl J.
    Gene; 1997 Jan 15; 184(2):263-72. PubMed ID: 9031638
    [Abstract] [Full Text] [Related]

  • 37. Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis.
    Kiener HP, Baghestanian M, Dominkus M, Walchshofer S, Ghannadan M, Willheim M, Sillaber C, Graninger WB, Smolen JS, Valent P.
    Arthritis Rheum; 1998 Feb 15; 41(2):233-45. PubMed ID: 9485081
    [Abstract] [Full Text] [Related]

  • 38. Improvements in the minimum binding sequence of C5a: examination of His-67.
    Or YS, Clark RF, Lane B, Mollison KW, Carter GW, Luly JR.
    J Med Chem; 1992 Jan 24; 35(2):402-6. PubMed ID: 1732557
    [No Abstract] [Full Text] [Related]

  • 39. Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.
    March DR, Proctor LM, Stoermer MJ, Sbaglia R, Abbenante G, Reid RC, Woodruff TM, Wadi K, Paczkowski N, Tyndall JD, Taylor SM, Fairlie DP.
    Mol Pharmacol; 2004 Apr 24; 65(4):868-79. PubMed ID: 15044616
    [Abstract] [Full Text] [Related]

  • 40. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes.
    Gasque P, Chan P, Fontaine M, Ischenko A, Lamacz M, Götze O, Morgan BP.
    J Immunol; 1995 Nov 15; 155(10):4882-9. PubMed ID: 7594492
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.